HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites.

Abstract
The synthesis of NAD (or NADP) from tryptophan involves a series of enzymes and the formation of a number of intermediates which are collectively called 'kynurenines.' In the late 1970s and early 1980s, it became clear that intraventricular administration of several 'kynurenines' could cause convulsions and that one of the 'kynurenines,' quinolinic acid, was an agonist of a sub-population of NMDA receptors and caused excitotoxic neuronal death. A related metabolite, kynurenic acid, could, on the other hand, reduce excitotoxin-induced neuronal death by antagonising ionotropic glutamate receptors. Since then, modifications in quinolinic and kynurenic acid synthesis have been proposed as a pathogenetic mechanism in Huntington's chorea and epilepsy. It was subsequently shown that a robust activation of the kynurenine pathway and a large accumulation of quinolinic acid in the central nervous system occurred in several inflammatory neurological disorders. More recently, it has been shown that 3OH-kynurenine or 3OH-anthranilic acid, two other kynurenine metabolites, may cause either apoptotic or necrotic neuronal death in cultures and that inhibitors of kynurenine hydroxylase may reduce neuronal death in in vitro and in vivo models of brain ischaemia or excitotoxicity. Finally, it has been reported that indole metabolites, indirectly linked to the kynurenine pathway, are able to modify neuronal function and animal behaviour by interacting with voltage-dependent Na+ channels. Oxindole, one of these metabolites, has sedative and anticonvulsant properties and accumulates in the blood and brain when liver function is impaired. In conclusion, a number of metabolites affecting brain function originate from tryptophan metabolism. Selective inhibitors of their forming enzymes may be useful to understand their role in physiology or as therapeutic agents in pathology.
AuthorsF Moroni
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 375 Issue 1-3 Pg. 87-100 (Jun 30 1999) ISSN: 0014-2999 [Print] Netherlands
PMID10443567 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Enzyme Inhibitors
  • Indoles
  • Receptors, N-Methyl-D-Aspartate
  • Kynurenine
  • Tryptophan
  • Hydrolases
  • kynureninase
Topics
  • Animals
  • Brain (pathology, physiology)
  • Brain Ischemia (pathology)
  • Enzyme Inhibitors (pharmacology)
  • Hydrolases (antagonists & inhibitors)
  • Indoles (metabolism, pharmacology)
  • Kynurenine (metabolism, pharmacology)
  • Receptors, N-Methyl-D-Aspartate (physiology)
  • Tryptophan (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: